Back
Voyager Therapeutics Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
34
VYGR
Voyager Therapeutics
Last Price:
6.58
Seasonality Move:
-0.12%
Buy
87
RYTM
Rhythm Pharmaceuticals
Last Price:
60.09
Seasonality Move:
9.98%
Sell
34
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy, Sell or Hold?
- The current Voyager Therapeutics [VYGR] share price is $6.69. The Score for VYGR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- VYGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $60.05. The Score for RYTM is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $6.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $60.05
The current trend is moderately bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
VYGR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 46.78 | Sell |
| Chaikin Money Flow: | -629491 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.57 - 7.41) | Sell |
| Bollinger Bands (100): | (6.21 - 8.15) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.69 | Buy |
| Relative Strength Index (14 RSI): | 60.03 | Buy |
| Chaikin Money Flow: | -795958 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.08 - 59.64) | Buy |
| Bollinger Bands (100): | (44.02 - 54.04) | Buy |
VYGR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.92 | Sell |
| 20-day SMA: | 6.98 | Sell |
| 50-day SMA: | 6.6 | Buy |
| 200-day SMA: | 7.83 | Sell |
| 8-day EMA: | 6.9 | Sell |
| 20-day EMA: | 6.89 | Sell |
| 50-day EMA: | 6.87 | Sell |
| 200-day EMA: | 7.52 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.6 | Sell |
| 20-day SMA: | 54.39 | Buy |
| 50-day SMA: | 51.92 | Buy |
| 200-day SMA: | 45.35 | Buy |
| 8-day EMA: | 60.8 | Sell |
| 20-day EMA: | 56.45 | Buy |
| 50-day EMA: | 52.55 | Buy |
| 200-day EMA: | 45.16 | Buy |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.78 per share, and a decrease next year of $0.36 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Voyager Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||